INVA (Innoviva) FFO


INVA Innoviva Inc INVA
89 GF Score
Price $23.64
GF Value $20.37
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Innoviva FFO?

FFO (Funds from operations) only applies to REITs.

INVA
89GF Score
Innoviva Inc INVA
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Innoviva (INVA) Overvalued in 2026?

Based on GuruFocus' analysis, Innoviva stock appears to be overvalued. The current stock price of $23.64 is trading 16.1% above its estimated GF Value™ of $20.37. GuruFocus considers Innoviva to be Modestly Overvalued.

Key valuation signals for INVA:

  • FFO:
  • GF Value™: $20.37 vs. price of $23.64 (16.1% above fair value)
  • GF Score™: 89/100 with 5 warning signs

No single metric tells the full story. See the INVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Innoviva Business Description

Other Exchanges HVE:Germany
Address 1350 Old Bayshore Highway, Suite 400, Burlingame, CA, USA, 94010
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
89GF Score

Get the complete analysis for INVA

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$23.64
Price
$20.37
GF Value